Cargando…
Bedside Peripheral Ultrasound-Guided Vascular Access in 253 Patients Hospitalized With COVID-19 Pneumonia: A Retrospective Italian Study
Background Several studies have recommended the use of vascular access in the treatment of COVID-19 patients. However, little is known about the utility and safety of using a peripheral ultrasound-guided vascular access device (UGVAD) at the bedside of hospitalized COVID-19 patients. To examine this...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110044/ https://www.ncbi.nlm.nih.gov/pubmed/35592209 http://dx.doi.org/10.7759/cureus.24157 |
_version_ | 1784709012832387072 |
---|---|
author | Oleari, Francesco Citterio, Chiara Bontini, Salvatore Grassi, Oriella Gozzo, Corrado Premoli, Jessica Mezzi, Maria Pia Roscio, Stefano Muroni, Monica Cremona, Gabriele Biasini, Claudia Mordenti, Patrizia Cavanna, Luigi |
author_facet | Oleari, Francesco Citterio, Chiara Bontini, Salvatore Grassi, Oriella Gozzo, Corrado Premoli, Jessica Mezzi, Maria Pia Roscio, Stefano Muroni, Monica Cremona, Gabriele Biasini, Claudia Mordenti, Patrizia Cavanna, Luigi |
author_sort | Oleari, Francesco |
collection | PubMed |
description | Background Several studies have recommended the use of vascular access in the treatment of COVID-19 patients. However, little is known about the utility and safety of using a peripheral ultrasound-guided vascular access device (UGVAD) at the bedside of hospitalized COVID-19 patients. To examine this, a retrospective monocenter study was carried out at the oncology-hematology department of Azienda Sanitaria di Piacenza, Italy. Methods We retrospectively analyzed data from three general hospitals in a district in North Italy on the positioning of UGVADs used with hospitalized COVID-19 patients. The positioning of the VAD was performed by a dedicated team using ultrasound guidance. The primary endpoint was the duration of VAD until the patient’s recovery or death. The secondary endpoints were complications of the use of VADs, which included vein thrombosis, infections, device malfunction, and viral contamination of the operators. Results Between February 21, 2020, and April 30, 2020, 253 consecutive hospitalized patients with COVID-19 pneumonia underwent UGVAD positioning. A midline was inserted in 88.53% of the patients, while peripheral central venous catheters and femoral central catheters were inserted in 9.88% and 1.59% of the patients, respectively. The mean lifespan of the VADs was 10.36±9.96 days (range: 1-73). Primary endpoint: The use of the VAD allowed the planned treatment in 92.88% of the patients; in the remaining 7.12%, the VAD was repositioned. Secondary endpoints: Complications of VAD were registered in 15.02% of the patients (dislocation, 9.49%; infection, 1.98%; thrombosis, 1.58%; occlusion, 1.19%; and malfunction, 0.79%). No contamination of the operators was registered. Discussion and conclusion With the limitation of being a retrospective study, our report suggests that ultrasound-guided positioning of VAD may allow the safe clinical management (drug infusion, hydration, parenteral nutrition, and phlebotomy) of hospitalized COVID-19 patients. The observance of recommended procedures protected all operators from infection. |
format | Online Article Text |
id | pubmed-9110044 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-91100442022-05-18 Bedside Peripheral Ultrasound-Guided Vascular Access in 253 Patients Hospitalized With COVID-19 Pneumonia: A Retrospective Italian Study Oleari, Francesco Citterio, Chiara Bontini, Salvatore Grassi, Oriella Gozzo, Corrado Premoli, Jessica Mezzi, Maria Pia Roscio, Stefano Muroni, Monica Cremona, Gabriele Biasini, Claudia Mordenti, Patrizia Cavanna, Luigi Cureus Infectious Disease Background Several studies have recommended the use of vascular access in the treatment of COVID-19 patients. However, little is known about the utility and safety of using a peripheral ultrasound-guided vascular access device (UGVAD) at the bedside of hospitalized COVID-19 patients. To examine this, a retrospective monocenter study was carried out at the oncology-hematology department of Azienda Sanitaria di Piacenza, Italy. Methods We retrospectively analyzed data from three general hospitals in a district in North Italy on the positioning of UGVADs used with hospitalized COVID-19 patients. The positioning of the VAD was performed by a dedicated team using ultrasound guidance. The primary endpoint was the duration of VAD until the patient’s recovery or death. The secondary endpoints were complications of the use of VADs, which included vein thrombosis, infections, device malfunction, and viral contamination of the operators. Results Between February 21, 2020, and April 30, 2020, 253 consecutive hospitalized patients with COVID-19 pneumonia underwent UGVAD positioning. A midline was inserted in 88.53% of the patients, while peripheral central venous catheters and femoral central catheters were inserted in 9.88% and 1.59% of the patients, respectively. The mean lifespan of the VADs was 10.36±9.96 days (range: 1-73). Primary endpoint: The use of the VAD allowed the planned treatment in 92.88% of the patients; in the remaining 7.12%, the VAD was repositioned. Secondary endpoints: Complications of VAD were registered in 15.02% of the patients (dislocation, 9.49%; infection, 1.98%; thrombosis, 1.58%; occlusion, 1.19%; and malfunction, 0.79%). No contamination of the operators was registered. Discussion and conclusion With the limitation of being a retrospective study, our report suggests that ultrasound-guided positioning of VAD may allow the safe clinical management (drug infusion, hydration, parenteral nutrition, and phlebotomy) of hospitalized COVID-19 patients. The observance of recommended procedures protected all operators from infection. Cureus 2022-04-15 /pmc/articles/PMC9110044/ /pubmed/35592209 http://dx.doi.org/10.7759/cureus.24157 Text en Copyright © 2022, Oleari et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Infectious Disease Oleari, Francesco Citterio, Chiara Bontini, Salvatore Grassi, Oriella Gozzo, Corrado Premoli, Jessica Mezzi, Maria Pia Roscio, Stefano Muroni, Monica Cremona, Gabriele Biasini, Claudia Mordenti, Patrizia Cavanna, Luigi Bedside Peripheral Ultrasound-Guided Vascular Access in 253 Patients Hospitalized With COVID-19 Pneumonia: A Retrospective Italian Study |
title | Bedside Peripheral Ultrasound-Guided Vascular Access in 253 Patients Hospitalized With COVID-19 Pneumonia: A Retrospective Italian Study |
title_full | Bedside Peripheral Ultrasound-Guided Vascular Access in 253 Patients Hospitalized With COVID-19 Pneumonia: A Retrospective Italian Study |
title_fullStr | Bedside Peripheral Ultrasound-Guided Vascular Access in 253 Patients Hospitalized With COVID-19 Pneumonia: A Retrospective Italian Study |
title_full_unstemmed | Bedside Peripheral Ultrasound-Guided Vascular Access in 253 Patients Hospitalized With COVID-19 Pneumonia: A Retrospective Italian Study |
title_short | Bedside Peripheral Ultrasound-Guided Vascular Access in 253 Patients Hospitalized With COVID-19 Pneumonia: A Retrospective Italian Study |
title_sort | bedside peripheral ultrasound-guided vascular access in 253 patients hospitalized with covid-19 pneumonia: a retrospective italian study |
topic | Infectious Disease |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110044/ https://www.ncbi.nlm.nih.gov/pubmed/35592209 http://dx.doi.org/10.7759/cureus.24157 |
work_keys_str_mv | AT olearifrancesco bedsideperipheralultrasoundguidedvascularaccessin253patientshospitalizedwithcovid19pneumoniaaretrospectiveitalianstudy AT citteriochiara bedsideperipheralultrasoundguidedvascularaccessin253patientshospitalizedwithcovid19pneumoniaaretrospectiveitalianstudy AT bontinisalvatore bedsideperipheralultrasoundguidedvascularaccessin253patientshospitalizedwithcovid19pneumoniaaretrospectiveitalianstudy AT grassioriella bedsideperipheralultrasoundguidedvascularaccessin253patientshospitalizedwithcovid19pneumoniaaretrospectiveitalianstudy AT gozzocorrado bedsideperipheralultrasoundguidedvascularaccessin253patientshospitalizedwithcovid19pneumoniaaretrospectiveitalianstudy AT premolijessica bedsideperipheralultrasoundguidedvascularaccessin253patientshospitalizedwithcovid19pneumoniaaretrospectiveitalianstudy AT mezzimariapia bedsideperipheralultrasoundguidedvascularaccessin253patientshospitalizedwithcovid19pneumoniaaretrospectiveitalianstudy AT rosciostefano bedsideperipheralultrasoundguidedvascularaccessin253patientshospitalizedwithcovid19pneumoniaaretrospectiveitalianstudy AT muronimonica bedsideperipheralultrasoundguidedvascularaccessin253patientshospitalizedwithcovid19pneumoniaaretrospectiveitalianstudy AT cremonagabriele bedsideperipheralultrasoundguidedvascularaccessin253patientshospitalizedwithcovid19pneumoniaaretrospectiveitalianstudy AT biasiniclaudia bedsideperipheralultrasoundguidedvascularaccessin253patientshospitalizedwithcovid19pneumoniaaretrospectiveitalianstudy AT mordentipatrizia bedsideperipheralultrasoundguidedvascularaccessin253patientshospitalizedwithcovid19pneumoniaaretrospectiveitalianstudy AT cavannaluigi bedsideperipheralultrasoundguidedvascularaccessin253patientshospitalizedwithcovid19pneumoniaaretrospectiveitalianstudy |